SARS-CoV-2 in Mexico: Beyond Detection Methods, Scope and Limitations
The new coronavirus that was first identified in December 2019 in Wuhan China, now called SARS-CoV-2, which causes the disease called COVID-19, has spread from China to the entire world in a few months. Due to its contagious potential (R0: 5.7) and because there is still no effective treatment to st...
Main Authors: | Cynthia Martinez-Liu, Natalia Martínez-Acuña, Daniel Arellanos-Soto, Kame Galan-Huerta, Sonia Lozano-Sepulveda, María del Carmen Martínez-Guzmán, Ana Maria Rivas-Estilla |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/1/124 |
Similar Items
-
Kinetics IgM and IgG SARS-CoV-2 in Recovery patients with Negative Evaluation RT-PCR
by: Jusup Endang, et al.
Published: (2023-11-01) -
Mycoplasma pneumoniae: IgG and IgM antibody response in presence of different antigens. Evaluation of commercial tests
by: Mariella Tonella, et al.
Published: (2011-12-01) -
Prevalence of serum antibodies to TORCH infection in the first trimester of the pregnancy in Kashan, Iran
by: sareh bagheri josheghani, et al.
Published: (2015-03-01) -
Prevalence of serum antibodies to TORCH infection in the first trimester of the pregnancy in Kashan, Iran
by: sareh bagheri josheghani, et al.
Published: (2015-03-01) -
Toxoplasmosis: Serious disease during pregnancy
by: Baghdad Science Journal
Published: (2011-03-01)